Clinical trials of a nasal spray developed by Israeli-founded. SaNOtize show it significantly reduces viral load and shortens the course of COVID-19 A report in The Lancet, the world’s most respected medical journal, concludes that its nitric oxide nasal spray (NONS) used  six times daily for seven days was “efficacious in accelerating the reduction of SARS-CoV-2 RNA from the nasal cavity”. The spray […]

While other global approvals were were focused on prevention, this is the first approval for SaNOtize nasal spray as early treatment for COVID-19.

Glenmark Pharmaceuticals will manufacture the spray in India and intends to produce, market and distribute it to other Asian countries.

Nasus Pharma developed the Taffix nasal gel which it says blocked SARS-CoV-2 and its British and South African variants in in vitro studies.

The Health Ministry gave interim approval to sell the spray to people aged 12 and over; UK clinical trial shows promising results.

Teva Pharmaceutical Industries reported positive results from Phase III clinical studies for its QNASL nasal spray. The spray is designed to treat seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). The trials tested the efficacy and safety of the spray, as well as the impact on quality of life. The results were reported at […]